Intervention to Improve the Delivery of Follow-up Care for Low-Risk Breast Cancer
Breast Cancer
About this trial
This is an interventional supportive care trial for Breast Cancer focused on measuring follow up care, low risk, health care delivery
Eligibility Criteria
Inclusion Criteria: Diagnosis of stage I, ER and/or PR positive, her2neu negative breast cancer within the last 6-24 monoths Willing to complete study procedures using email Exclusion Criteria: Receipt of chemotherapy for the stage I ER and/or PR positive, her2neu negative breast cancer diagnosed within the last 6-24 months Participants will be excluded if they are unable to read and write in English or if, in the opinion of a treating clinician, have cognitive impairment that would prevent completion of study procedures Pregnancy, based on patient self-report. If a patient becomes pregnant during the study period, they will be removed from the study at that time. Diagnosis of a ER and PR negative, her2neu negative breast cancer or a her2neu positive breast cancer within the last 5 years
Sites / Locations
- UW Health Oncology ClinicsRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
REASSURE Follow Up care
Usual Follow Up Care